Ainos receives Taiwan approval for VELDONA clinical study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. RH
3. SPCX
4. USO
5. ELVN
6. NVDA
7. BBW
8. RKLB
9. NDAQ
10. VG

Go back to Ainos receives Taiwan approval for VELDONA clinical study
(NASDAQ: AIMD) Delayed: 1.92 --0 (-0%)
Previous Close $1.92    52 Week High $ 
Open $1.92    52 Week Low $ 
Day High $1.92    P/E N/A 
Day Low $1.92    EPS $ 
Volume 572       

(NASDAQ: AIMDW) Delayed: 0.15 --0 (-0%)
Previous Close $0.15    52 Week High $ 
Open $0.15    52 Week Low $ 
Day High $0.15    P/E N/A 
Day Low $0.15    EPS $ 
Volume 12,963